ADD ANI AS A TRUSTED SOURCE
Add ANI as a Trusted Source for Reliable Information
Menu
Serum Institute to resume COVID-19 vaccine trials in India...
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus...
DCGI directs Serum Institute to suspend any new recruitment...
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered...
Serum Institute says will adhere to DCGI instructions after...
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a...
Telangana: Junior Assistant, office subordinate arrested for...
Karimnagar (Telangana) [India], September 8 (ANI): A junior Assistant and a subordinate at the office of the...
Serum Institute initiates phase 2, 3 clinical study on 1,600...
New Delhi [India], August 19 (ANI): Indian pharmaceutical giant Serum Institute of India has initiated the phase 2,...
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Hyderabad (Telangana) [India], Aug 19 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Avigan...
DGCI nod for Apheresis machine to extract blood plasma in Goa
Panaji (Goa) [India], Aug 4 (ANI): Goa has made a new breakthrough in its plasma therapy for critically ill...
DCGI gives nod to Serum Institute to hold Phase II, III COVID...
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of...
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3...
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted...
COVID-19: Health Ministry directs DCGI to ensure equitable...
New Delhi [India], July 29 (ANI): The Union Health and Family Welfare Ministry has directed the Drugs Controller...
COVID-19: Health ministry decides not to put Itolizumab in...
New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab...
Domestic pharma giant SII applies to DCGI for phase 2/3...
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.